Simcere Pharma kicks off $461m Hong Kong IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

Simcere Pharma kicks off $461m Hong Kong IPO

Jonathan Breen
October 13, 2020 09:15 AM
biopharma_stocks_adobe_575x375.jpg

Simcere Pharmaceutical Group has begun its Hong Kong listing, opening books for the up-to HK$3.57bn ($460.6m) deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsHealth and BiotechUBSEquityChina Merchants Bank CoChinaChina International Capital CorpHong Kong SARAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificEmerging MarketsSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article